grants awarded

Cincinnati Children's Hospital Medical Center - $155,000 (January 2012)

Establishment of an International DIPG Registry
Grant Information
Thank You Letter

Texas Children's Hospital - $100,000 (November 2011)

Eliminating Therapy–Resistant Diffuse Intrinsic Pontine Gliomas with Oncolytic Picorna Virus SVV-001: an in vivo Study in Intra-brain Stem Xenograft Mouse Models
Grant Information
Thank You Letter

Duke Children's Hospital & Health Center - $82,049 (November 2011)

Preclinical evaluation of systemic and direct delivery of a PDGFR-alpha antibody
Grant Information
Thank You Letter

Doernbecher Children's Hospital - $100,000 (November 2011)

Rapid Preclinical Development of a Targeted Therapy Combination for DIPG
Grant Information
Thank You Letter

Sydney Children's Hospital - $100,000 (August 2011)

Rapid Development of Targeted Therapies
Grant Information
Media Release

St. Jude Children's Research Hospital - $35,000 (September 2010)

Signaling Effectors in Diffuse Intrinsic Potine Glioma (DIPG)
Grant Information
Thank You Letter

Cincinnati Children's Hospital Medical Center - $35,000
(September 2010)

Establishment of a pre-clinical model for prediatric glioblastoma
Grant Information
Thank You Letter

Cincinnati Children’s Hospital Medical Center - $75,000 (March 2010)

Telomerase: A Therapeutic Target in Pediatric Brain Tumors
Grant Information
Thank You Letter

Weill Medical College of Cornell University and Memorial Sloan-Kettering Cancer Hospital - $91,740 (March 2010)

Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.
Grant Information
Website
Thank You Letter

St. Jude Children’s Research Hospital - $50,000 (July, 2009)

Phase I Study of the combination of Vandetanib and Dasatanib administered during and after radiation therapy in the children with newly diagnosed DIPG.
Grant Information
Website
Thank You Letter

Cincinnati Children’s Hospital Medical Center - $50,000 (July, 2009)

National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
Grant Information
Thank You Letter

St. Jude Children’s Research Hospital - $10,000 (July, 2009)
(in association with Smiles for Sophie Forever)

Second phase of genetic analysis of DIPG.
Grant Information
Thank You Letter

Cincinnati Children’s Hospital Medical Center - $50,000
(September, 2008)

Study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
Grant Information

St. Jude Children’s Research Hospital - $25,000 (September, 2008)

A multi-institutional study in which an extensive analysis of the genetic make-up of brainstem gliomas will be performed to gain a better understanding of the underlying genetic abnormalities.
Grant Information
Thank You Letter
Prospective Collection of Tissue Samples
at Autopsy Effectiveness